Form 4: Tempus AI Director Sells Shares Under 10b5-1 Plan

Tempus AI Director David R. Epstein sold 250 shares of Class A Common Stock for $75.55 per share, reducing his direct beneficial ownership to 26,421 shares.

Summary

• David R. Epstein, a Director of Tempus AI, Inc. (TEM), reported a transaction involving the company's Class A Common Stock.
• The transaction, a sale of 250 shares, occurred on December 1, 2025, at a price of $75.55 per share.
• This sale was executed pursuant to a Rule 10b5-1 trading plan adopted by Mr. Epstein on August 27, 2024.
• Following this transaction, Mr. Epstein directly beneficially owns 26,421 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: A routine insider sale executed under a pre-arranged 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new information. This is generally considered neutral in terms of company sentiment.

Positives

• The transaction was conducted under a pre-arranged Rule 10b5-1 trading plan, indicating a planned liquidity event rather than a reaction to new, non-public information.

Negatives

• A director's sale of shares, even if pre-planned, reduces their direct ownership stake in the company.

Risks

• No specific risks were mentioned in this Form 4 filing, which primarily reports an insider transaction.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This insider transaction report is a routine disclosure required by the SEC for company directors and officers. It does not provide information directly related to broader industry trends or competitive landscape, but rather details an individual's stock activity.

Comparison to Industry Standards

• Insider sales executed under Rule 10b5-1 plans are a common practice across industries for executives and directors to manage personal finances and diversify holdings while adhering to insider trading regulations. This transaction aligns with standard corporate governance practices for managing insider stock sales.

Corporate Governance

Stakeholder Impact

• Shareholders: The sale of 250 shares by a director is a relatively small amount compared to the total outstanding shares and the director's remaining holdings, suggesting minimal direct impact on shareholder value or perception.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

The filing reports a routine insider sale by a director under a pre-arranged 10b5-1 plan. This type of transaction typically does not signal new material information about the company's prospects and is often for personal liquidity or diversification purposes. Therefore, it does not warrant a change in investment recommendation based solely on this filing.

Keywords

Tempus AI, TEM, Insider Sale, Form 4, David R. Epstein, Director, Stock Transaction, 10b5-1 Plan